European Archives - Page 169 of 1175 - European Medical Journal

The 2025 pharma forecast

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Antidepressant Prescriptions: An Early Warning of Sporadic Creutzfeldt-Jakob Disease?

Mood alterations linked to sporadic Creutzfeldt-Jakob disease: Study finds rising SSRI prescriptions years before symptom onset.

Key Risk Factors for Mortality in Patients With Sjögren’s Disease

A study finds Sjögren’s disease patients have 70% higher mortality risk, with infections, cancers, cardiovascular issues, and factors like age, low C4, and heart failure.

Mobile App Reduces Opioid Misuse After Caesarean Section

Mobile app reduces opioid misuse after cesarean section, optimising prescriptions and mitigating public health risks.

BRCA1/BRCA2 Carriers Face Elevated Risk of Second Cancers

BRCA1/BRCA2 carriers face significantly higher risks of second cancers, including ovarian and pancreatic, after breast cancer.

15% of Children Aged Under 3 Years Receive Invalid Vaccine Doses

Research reveals that 15% of children aged 0–35 months in the USA received at least one invalid vaccine dose between 2011–2020.

Wearable Tech Predicts IBD Flares Weeks in Advance

Wearable devices like Apple Watches, Fitbits, and Oura Rings could revolutionise inflammatory bowel disease (IBD) management.

Exploring Hepatocellular Carcinoma: Massimo Colombo

EMJ is thrilled to present an interview with Massimo Colombo, Past Professor of Gastroenterology at the University of Milan, Italy, that…

Study Explores Acne Relapse Rates After Isotretinoin

The study revealed that 22.5% of patients experienced acne relapse, and 8.2% required isotretinoin retrial.

Takeda takes lead role in Crohn’s Disease biomarker study

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.